The ~ 20-fold higher expression of Slc25a3 in mice compared to rats, alongside its marked reduction in STZ-icv rats and AD patients, suggests that the greater Slc25a3 reserve in mice may contribute to their reduced susceptibility to STZ-icv-induced cognitive deficits. This evidence concerns the gene SLC25A3 and Alzheimer disease.